首页> 外文OA文献 >Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas

【2h】

Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas

机译：Zeste同源物2（EZH2）蛋白在小细胞和腐蚀性B细胞非霍奇金淋巴瘤中的差异表达，P-ERK1 / 2和MYC在侵袭性B细胞淋巴瘤中的差异调节

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Xuejun Tian; Ashley Pelton; Ali Shahsafaei; David M Dorfman;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas [J] . Xuejun Tian, Ashley Pelton, Ali Shahsafaei, Modern Pathology . 2016,第9期

机译：zeste同源2（EZH2）蛋白增强子在小细胞和侵袭性B细胞非霍奇金淋巴瘤中的差异表达以及p-ERK1 / 2和MYC对侵袭性B细胞淋巴瘤中EZH2表达的差异调节
2. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas [J] . Tian Xuejun, Xu Jie, Dorfman David M. American Journal of Surgical Pathology . 2019,第1期

机译：EZH2，P-ERK1 / 2，P-STAT和MICC表达组合的效用在EZH2阳性霍奇金淋巴瘤和相关大B细胞淋巴瘤的差异诊断中
3. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas. [J] . Loddenkemper C, Anagnostopoulos I, Hummel M, Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland . 2004,第1期

机译：在反应性B细胞，B细胞非霍奇金淋巴瘤和霍奇金淋巴瘤中，E增强子活性和BOB.1 / OBF.1，Oct2，PU.1和免疫球蛋白的表达差异。
4. Expression profile of HIP1R in B-cell subsets and in silico prediction of its functions in diffuse large B-cell lymphoma [C] . Kah Keng Wong, Alison H Banham International Conference on Intelligent Informatics and Biomedical Sciences . 2018

机译：HIP1R在B细胞亚群中的表达特征及其在弥漫性大B细胞淋巴瘤中的功能的计算机预测
5. Regulation of CD20 in rituximab-resistant cell lines (RRCL) and B-cell non-Hodgkin's lymphoma (B-NHL) [D] . Tsai, Ping-Chiao 2012

机译：CD20在利妥昔单抗耐药细胞系（RRCL）和B细胞非霍奇金淋巴瘤（B-NHL）中的调节
6. Coordinated Silencing of Myc-Mediated miR-29 by HDAC3 and EZH2 As a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas [O] . Xinwei Zhang, Xiaohong Zhao, Warren Fiskus, -1

机译：通过HDaC3和EZH2的myc介导的miR-29的沉默协调作为组蛋白修饰的在侵蚀性B细胞淋巴瘤的治疗靶标
7. Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity [O] . X Zhao, T Lwin, X Zhang, 2013

机译：Myc-miRNA-ezH2环的破坏以抑制侵袭性B细胞淋巴瘤的存活和克隆因度

Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas

著录项

相似文献

相关主题

期刊订阅